Key Insights

Highlights

Success Rate

92% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 37/100

Termination Rate

1.8%

1 terminated out of 56 trials

Success Rate

92.3%

+5.8% vs benchmark

Late-Stage Pipeline

5%

3 trials in Phase 3/4

Results Transparency

42%

5 of 12 completed with results

Key Signals

5 with results92% success

Data Visualizations

Phase Distribution

35Total
Not Applicable (10)
Early P 1 (1)
P 1 (2)
P 2 (19)
P 3 (3)

Trial Status

Unknown20
Recruiting17
Completed12
Not Yet Recruiting4
Active Not Recruiting2
Terminated1

Trial Success Rate

92.3%

Benchmark: 86.5%

Based on 12 completed trials

Clinical Trials (56)

Showing 20 of 20 trials
NCT05893888Phase 2RecruitingPrimary

A Study Evaluating the Safety and Efficacy of PRV111, PRV211, and PRV131 in Subjects With Oral and Lung Cancers

NCT06876038Phase 2Not Yet Recruiting

Low-cost Screening and Image-guided Photodynamic Therapy (PDT) of Premalignant and Malignant Oral Lesions

NCT06627270Phase 2RecruitingPrimary

Antibiotic Treatment Effects on Intratumoral Bacteria Modulation in Surgical Patients With Oral Cancer

NCT06336941Not ApplicableRecruitingPrimary

"Ultra-High Frequency intraOral UltraSonography of the TONgue" (HOUSTON)

NCT07063212Phase 2Recruiting

A Study of Sacituzumab Govitecan in Combination With Cetuximab in People With Head and Neck Squamous Cell Cancer (HNSCC)

NCT05551117Phase 2Terminated

A Study of Vobramitamab Duocarmazine in Participants With Metastatic Castration Resistant Prostate Cancer and Other Solid Tumors

NCT07343271RecruitingPrimary

Dual-energy CT vs. MRI in the Evaluation of Squamous Cell Carcinomas of the Oral Cavity and Oropharynx

NCT06009861Phase 2Active Not RecruitingPrimary

Neoadjuvant Tislelizumab Plus Chemotherapy for Locally Advanced Oral/Oropharyngeal Cancer (NeoSPOT)

NCT06055868Recruiting

People Living With HIV, Oral and Oropharyngeal Cancer, and Health Equity

NCT06321003RecruitingPrimary

SYsteMatical Trained learnIng aLgorithms for Oral carcInogenesiS Interpretation by Optical Coherence Tomography

NCT06258811Phase 3RecruitingPrimary

Neoadjuvant Immunochemotherapy for LAOSCC

NCT06174428Recruiting

Validity of Viome's Oral/throat Cancer Test

NCT05451303RecruitingPrimary

Detection of Oral and Throat Cancers Using OralViome Cancer Testing System

NCT04883645Early Phase 1CompletedPrimary

Neoadjuvant Imiquimod Immunotherapy for Oral Cancer

NCT04649476Phase 2CompletedPrimary

Neoadjuvant PD-1 Blockade in Resectable Oral Squamous Cell Carcinoma

NCT06031337Completed

Salivary Expression of SOX7 in Oral Squamous Cell Carcinoma: Diagnostic Accuracy Study

NCT04718415Phase 2Active Not RecruitingPrimary

Neoadjuvant Sintilimab in Combination With Carboplatin and Nab-paclitaxel in Resectable Oral Cavity or Oropharyngeal Squamous Cell Carcinoma

NCT05719779Not ApplicableRecruiting

Tolerance and Benefits of Mandibular Advanced Device for Snoring and Sleep Apnea in Oropharyngeal Cancer.

NCT06438939Not ApplicableNot Yet RecruitingPrimary

NBI for Early Diagnosis of OPMD/OSCC

NCT05798793Phase 3RecruitingPrimary

Neoadjuvant Anti-PD-1 Immunotherapy With Chemotherapy in Resectable Locally Advanced Oral Squamous Cell Carcinoma

Scroll to load more

Research Network

Activity Timeline